Research Centers of Excellence

Clinical Trials

Research Funding

LBD is the Most Expensive Dementia in America

Dementia is one of the most expensive diseases in the United States, increasing healthcare costs 3 times over those without dementia. Until now, studies on the costs of different dementia […]
Read More

Updated LBD Research Recommendations Published

Every 3 years, a national research summit is held to update research strategies for non-Alzheimer’s dementias. This 2-day national event is one of 3 rotating summits held in response to […]
Read More

Increased Hospitalization in DLB Compared to AD

A study out of the U.K. revealed that people with one form of LBD, specifically, dementia with Lewy bodies and more frequently admitted to general hospitals that people with Alzheimer’s […]
Read More

Adult Day Service Boosts Beneficial Stress Hormone in Caregivers

A new study reveals family caregivers have an increase in the beneficial stress hormone DHEA-S on days when they use an adult day service for their relatives with dementia. DHEA-S […]
Read More

Sleep Disorder Increases Odds of DLB by Five Times Over Alzheimer’s

REM sleep behavior disorder (RBD) is a condition that causes a person to physically act out their dreams and is a common in Lewy body dementia (LBD). RBD is a […]
Read More

LBD Places a High Toll on Families

The combination of cognitive, motor and behavioral symptoms early in the course of LBD creates a highly challenging set of demands for continuing care. Recent studies demonstrate that LBD families […]
Read More

Positive Results for the HARMONY Clinical Trial of Pimavanserin in Dementia-Related Psychosis

In December ACADIA Pharmaceuticals presented its top-line results from its Phase 3 clinical trial of pimavanserin in people who had dementia-related psychosis. The results had been eagerly awaited; ACADIA stopped […]
Read More

LBD Diagnostic Symptoms Checklist

Because Lewy body dementia is the most misdiagnosed form of dementia, LBDA developed a useful checklist to help physicians and their patients identify key LBD symptoms used to make a […]
Read More

National Institutes of Health Award $14 million for LBD Research

People who have LBD plus changes in the brain associated with Alzheimer’s disease tend to have more aggressive disease progression. However, science has not yet explained why these two disease […]
Read More

Research Advance: DLB Genetics Uniquely Different from Parkinson’s

The human genome is a complete set of a person’s DNA. Serving as a blueprint for all cells in the body, the genome contains about 20,000 genes. The first human […]
Read More
VIEW ALL